Clinical Trial Update: Relationship Between Natural Killer Cells' Ability to Kill Leukemia Cells and the Outcome of Patients With Acute Myeloid Leukemia Previously Treated With Interleukin-2

View source ↗

Summary

Completed clinical trial studying whether natural killer cells' ability to kill leukemia cells correlates with outcomes in patients with acute myeloid leukemia …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Interleukin-2 (interleukin-2)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Leukemia | Status: COMPLETED